These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15153660)

  • 1. Changes in blood viscosity with mucopolysaccharide polysulfate.
    Hitosugi M; Omura K; Kido M; Kawato H; Niwa M; Nagai T; Tokudome S
    J Pharmacol Sci; 2004 May; 95(1):132-4. PubMed ID: 15153660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in blood viscosity with synthetic protease inhibitors.
    Hitosugi M; Niwa M; Takahashi T; Kurosu A; Nihei H; Nagai T; Tokudome S
    J Pharmacol Sci; 2003 Apr; 91(4):334-6. PubMed ID: 12719663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in blood viscosity by heparin and argatroban.
    Hitosugi M; Niwa M; Takatsu A
    Thromb Res; 2001 Dec; 104(5):371-4. PubMed ID: 11738080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemocoagulation and hemorheology in heart failure and the possible effects of glycosaminoglycans].
    Spinar J; Novotný J; Mayer J; Vítovec J; Spinarová L
    Vnitr Lek; 1995 Jan; 41(1):3-7. PubMed ID: 7716890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies on the topical administration of mucopolysaccharide and heparin ointments in nonhuman primates.
    Hoppensteadt DA; Neville B; Schultz C; Jeske W; Raake W; Fareed J
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):13-20. PubMed ID: 19959490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates.
    Hoppensteadt DA; Fareed J; Raake P; Raake W
    Thromb Res; 2001 Jul; 103(2):157-63. PubMed ID: 11457474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic effect of a mucopolysaccharide polysulfate after systemic, topical and percutaneous application.
    Görög P; Raake W
    Arzneimittelforschung; 1987 Mar; 37(3):342-5. PubMed ID: 2954557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of rheologic disorders of the blood in patients with uterine myoma in the postoperative period].
    Kirsanova MI; Karapetian SG
    Akush Ginekol (Mosk); 1990 Feb; (2):27-30. PubMed ID: 2339758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of sodium nitroprusside on coagulative and rheologic properties of the blood in patients in the acute period of myocardial infarction].
    Zabelin IV; Solov'ev VV; Barinov VG; Evdokimov VV; Shvedova LP
    Kardiologiia; 1990 Feb; 30(2):90-1. PubMed ID: 2348629
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant properties of three mucopolysaccharides used in rheumatology.
    Bauer F; Schulz P; Reber G; Bouvier CA
    Thromb Haemost; 1983 Oct; 50(3):652-5. PubMed ID: 6228031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-dose oral triphasic contraceptives on blood viscosity, coagulation and lipid metabolism.
    Coata G; Ventura F; Lombardini R; Ciuffetti G; Cosmi EV; Di Renzo GC
    Contraception; 1995 Sep; 52(3):151-7. PubMed ID: 7587186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB; Edward M; Winter JH; Bennett NB
    Thromb Res; 1980 Feb 1-15; 17(3-4):539-44. PubMed ID: 6768163
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnetoelastic transducers for monitoring coagulation, clot inhibition, and fibrinolysis.
    Puckett LG; Lewis JK; Urbas A; Cui X; Gao D; Bachas LG
    Biosens Bioelectron; 2005 Mar; 20(9):1737-43. PubMed ID: 15681188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1980 Aug; 69(4):675-7. PubMed ID: 6159941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II].
    Zhang G
    Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):126-9. PubMed ID: 15622771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowering of plasma viscosity by the oral administration of the glycosaminoglycan sulodexide in patients with peripheral vascular disease.
    Lunetta M; Salanitri T
    J Int Med Res; 1992 Feb; 20(1):45-53. PubMed ID: 1568519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on the antithrombotic effects of Holothuria ldeucospilota acidic mucopolysaccharide].
    Wang X; Wang H; Hu D; Li J; Jin C; Lu S; Jiang C; Qu B; Li J
    Zhonghua Xue Ye Xue Za Zhi; 1997 Sep; 18(9):457-9. PubMed ID: 15625835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxia of deep venous thrombosis, due to haemodilution.
    Duruble M
    Phlebologie; 1982; 35(1):143-72. PubMed ID: 7071168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.